Ace Therapeutics is a global ophthalmology CRO. Our services involve the whole preclinical process of drug development, including drug discovery, proof of concept to early evaluation, and effective modeling of preclinical research, etc. We are investing in more possible research aspects of ophthalmology.
Ace Therapeutics has extensive experience in the development of ophthalmic product as well as novel drug delivery strategies. Not only do we provide customers with development services for ophthalmic products, but we can also choose the best drug delivery method according to the type and location of the disease. Our administration methods involves multiple routes,including systemic delivery, intravitreal injection, subconjunctival injection, anterior chamber injection and so on.
Learn MoreIn the ophthalmic preclinical research services provided by Ace Therapeutics, we develope live animal models, ocular pharmacodynamics, toxicology and ocular pharmacokinetics, etc. In addition, Ace Therapeutics stands with its partners to design the best customized solutions to facilitate project management and development.
Learn MoreAce Therapeutics offers a variety of in vivo animal models that mimic the conditions and diseases of the human eye. We can not only help customers choose the appropriate in vivo drug efficacy model, but also design, verify, and develop new efficacy models according to the specific requirements of our customers. Our in vivo ocular disease models involve multiple species, including mice, rats, guinea pigs, rabbits, dogs, and zebrafish.
Learn MoreAce Therapeutics is a provider of comprehensive ophthalmic solutions, and has gradually developed into a comprehensive biotechnology company since its establishment.